Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Medulloblastoma 5Glioma 4Glioblastoma 4Sarcoma, Ewing 3Sarcoma 3Rhabdomyosarcoma 3Rhabdoid Tumor 3Neuroblastoma 3Breast Neoplasms 3Brain Neoplasms 3Astrocytoma 3Wilms Tumor 2Osteosarcoma 2Oligodendroglioma 2Neuroectodermal Tumors, Primitive, Peripheral 2Lymphoma, Non-Hodgkin 2Histiocytosis, Langerhans-Cell 2Hepatoblastoma 2Ependymoma 2Xanthogranuloma, Juvenile 1Uterine Neoplasms 1Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Thyroid Neoplasms 1Stomach Neoplasms 1Recurrence 1Rectal Neoplasms 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Ovarian Neoplasms 1

Interventions

Valproic Acid 2Temozolomide 2Oncolytic Virotherapy 2Magnetic Resonance Spectroscopy 22-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 2vorasidenib 1trametinib 1sonidegib 1ribociclib 1pembrolizumab 1palbociclib 1mirdametinib 1interferon gamma-1b 1imetelstat 1gallium Ga 68 dotatate 1fluorodopa F 18 1Verteporfin 1Radiotherapy 1ONC206 1Interleukin-12 1Interferon-gamma 1Immunotherapy 1Immunologic Techniques 1Granulocyte Colony-Stimulating Factor 1Gemcitabine 1Filgrastim 1Doxorubicin 1Dexamethasone 1Cyproheptadine 1Calcium Dobesilate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplasms, Neuroepithelial × palbociclib × CNS × Clear all
NCT02255461 2021-03-02

Palbociclib Isethionate in Treating Younger Patients With Recurrent, Progressive, or Refractory Central Nervous System Tumors

Pediatric Brain Tumor Consortium

Phase 1 Terminated
35 enrolled 28 charts
CNS

Astrocytoma, Glioblastoma, Medulloblastoma, Oligodendroglioma, Choroid Plexus Neoplasms, Neoplasms, Neuroepithelial

Data powered by HemOnc (CC BY 4.0) Colophon âš¡